Age-Dependent Decrease of DNA Hydroxymethylation in Human T Cells
Thien Phu Truong, Mamiko Sakata-Yanagimoto, Momoko Yamada, Genta Nagae, Terukazu Enami, Rie Nakamoto-Matsubara, Hiroyuki Aburatani, Shigeru Chiba, Thien Phu Truong, Mamiko Sakata-Yanagimoto, Momoko Yamada, Genta Nagae, Terukazu Enami, Rie Nakamoto-Matsubara, Hiroyuki Aburatani, Shigeru Chiba
Abstract
Hydroxymethylcytosine (hmC) is a natural nucleobase, which is converted from methylcytosine (mC) by tet methylcytosine dioxygenase (TET) family (TET1-3) enzymes. Decrease of genomic hmC is postulated to confer a risk for myeloid-lineage as well as T-cell neoplasms, based on the fact that loss-of-function mutations in the TET2 gene were frequently identified in these diseases. The relationship between hmC and aging remains to be elucidated. Here, we demonstrated that hmC content decreased with age in the peripheral blood T cells of 53 human volunteers. We further identified that the mRNA expression levels of TET1 and TET3 decreased with age, while those of TET2 were not influenced by age. The genomic hmC content was correlated with the mRNA expression level of TET3, but not those of TET1 and TET2. Our study suggests the presence of new epigenetic regulatory mechanisms in aging T cells.
Source: PubMed
다가오는 임상 시험
-
NCT07826949아직 모집하지 않음
-
NCT07826962아직 모집하지 않음
-
NCT07826975아직 모집하지 않음
-
NCT07826988아직 모집하지 않음
-
NCT07827001모병뇌암 | CNS 암 | 신경계 암 | 뇌전이암
-
NCT07827027아직 모집하지 않음
-
NCT07827040모병
-
NCT07827053아직 모집하지 않음
-
NCT07827066아직 모집하지 않음금연 | AI 에이전트 | Early-Stage Cancer
-
NCT07827131아직 모집하지 않음